Brief: Dimerix And FUSO Enter Into Exclusive Development And License Agreement To Commercialise DMX-200 In Japan

Fuso Pharmaceutical Industries

07/01/2025 24:39

Jan 7 (Reuters) - Dimerix Ltd  DXB.AX :
    * DIMERIX AND FUSO ENTER INTO EXCLUSIVE DEVELOPMENT AND
LICENSE
AGREEMENT TO COMMERCIALISE DMX-200 IN JAPAN


Further company coverage:  DXB.AX 

 ((Reuters.Briefs@thomsonreuters.com;))